Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
Saved in:
| Title: | Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer. |
|---|---|
| Authors: | de Almeida, Daniel Vargas P.1,2, Anderson, Justine M.1,3, Danila, Daniel C.1,4, Morris, Michael J.1,4, Slovin, Susan F.1,4, Abida, Wassim1,4, Cohn, Erica D.1,5, Baser, Raymond E.6, Scher, Howard I.1,4,7, Autio, Karen A.1,4 AutioK@mskcc.org |
| Source: | Journal of Immunotherapy & Precision Oncology. Nov2023, Vol. 6 Issue 4, p162-169. 8p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 174222400 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22de+Almeida%2C+Daniel+Vargas+P%2E%22">de Almeida, Daniel Vargas P.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Anderson%2C+Justine+M%2E%22">Anderson, Justine M.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Danila%2C+Daniel+C%2E%22">Danila, Daniel C.</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Morris%2C+Michael+J%2E%22">Morris, Michael J.</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Slovin%2C+Susan+F%2E%22">Slovin, Susan F.</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Abida%2C+Wassim%22">Abida, Wassim</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Cohn%2C+Erica+D%2E%22">Cohn, Erica D.</searchLink><relatesTo>1,5</relatesTo><br /><searchLink fieldCode="AR" term="%22Baser%2C+Raymond+E%2E%22">Baser, Raymond E.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Scher%2C+Howard+I%2E%22">Scher, Howard I.</searchLink><relatesTo>1,4,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Autio%2C+Karen+A%2E%22">Autio, Karen A.</searchLink><relatesTo>1,4</relatesTo><i> AutioK@mskcc.org</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Immunotherapy+%26+Precision+Oncology%22">Journal of Immunotherapy & Precision Oncology</searchLink>. Nov2023, Vol. 6 Issue 4, p162-169. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174222400 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.36401/JIPO-23-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 162 Titles: – TitleFull: Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: de Almeida, Daniel Vargas P. – PersonEntity: Name: NameFull: Anderson, Justine M. – PersonEntity: Name: NameFull: Danila, Daniel C. – PersonEntity: Name: NameFull: Morris, Michael J. – PersonEntity: Name: NameFull: Slovin, Susan F. – PersonEntity: Name: NameFull: Abida, Wassim – PersonEntity: Name: NameFull: Cohn, Erica D. – PersonEntity: Name: NameFull: Baser, Raymond E. – PersonEntity: Name: NameFull: Scher, Howard I. – PersonEntity: Name: NameFull: Autio, Karen A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 26662345 Numbering: – Type: volume Value: 6 – Type: issue Value: 4 Titles: – TitleFull: Journal of Immunotherapy & Precision Oncology Type: main |
| ResultId | 1 |
